Pancare Foundation Market Research Report

Company Overview

Name and Mission

• Name: Pancare Foundation

• Mission: To improve survival rates and support for Australians diagnosed with pancreatic, liver, stomach, biliary, and oesophageal cancers, from the point of diagnosis through to treatment and beyond.

Founding Details

• Founded: No information is available

• Founders: No information is available

Key People

• Chief Executive Officer: Doug Hawkins

• Chairman of the Board: Clive Appleton

• Board Members:

• Dr. Mehrdad Nikfarjam

• Rod Cairnduff

• Douglas Rowe

• Paul McDonald

• Angeline Nicholas

• Kate O’Sullivan

Headquarters

• Location: 70 Yarra Street, Heidelberg Victoria 3084, Australia

Number of Employees

• No information is available

Revenue

• No information is available

Known For

• The Pancare Foundation is renowned for its dedication to raising awareness, supporting families, and funding research for upper gastrointestinal (GI) cancers, which include pancreatic, liver, stomach, biliary, and oesophageal cancers.

Products

Products Offered

• My Care KIT

• High-level Description: A comprehensive A5 binder designed to help individuals navigate living with upper GI cancer.

• Key Features:

• Series of booklets and information sheets on a variety of topics.

• Space to record personal cancer experiences to share with the treating team.

• PanSupport Service

• High-level Description: A dedicated support, resource, and information service for Australians affected by upper GI cancers.

• Key Features:

• Online hub with resources on diagnosis, treatment options, and health and wellbeing.

• Specialist Upper GI Cancer Nurses and Support Managers.

• Support groups and counselling services.

• Educational webinars appropriate for patients, families, and healthcare professionals.

Recent Developments

New Appointments

• September 5, 2024

• Development: Appointment of Kate O’Sullivan to Pancare's Board of Directors.

• Impact: Strengthens leadership with her expertise in investment, marketing, client relationship management, and business strategy.

Support for New Therapies

• September 3, 2024

• Development: Advocacy for treatments such as Tislelizumab (Tevimbra®) for oesophageal squamous cell carcinoma and Irinotecan (Onivyde®) for metastatic pancreatic adenocarcinoma.

• Impact: Submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) regarding the listing of these therapies on the Pharmaceutical Benefits Scheme (PBS).

Community Engagement

• Unite for Hope Fundraisers

• Events: Held in Echuca, Mansfield, Sydney, and other locations.

• Funds Raised: Nearly $70,000.

• Impact: Supports patient services and funds research into early detection and new treatments through community involvement.

Research Programs

• Strategic Plan (2020-2025)

• Focus Areas:

• Discovery of new treatments.

• Early detection.

• Personalized medicine strategies.

• Optimal patient care.

• Support and development of future leaders.

• Support of clinical trials.

Other Developments

• May 17, 2024

• Content: Personal stories to raise awareness and provide social and emotional support, such as Annabel Martin’s narrative on losing a parent to Biliary cancer.

• Awareness Campaigns

• Month-Long Awareness Activities:

• September: Oesophageal Cancer Awareness.

• February: Gallbladder and Bile Duct Cancer Awareness.

By leveraging both patient and professional expertise, Pancare Foundation continues to grow its impact through innovative research, comprehensive support services, and active community engagement.